Courchesne; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Courchesne; Marc.The latest application filed is for "spirotropane compounds".

Company Profile

0.13.9

Courchesne; Marc - Laval N/A CA
Courchesne; Marc - Quebec CA
Courchesne; Marc - Laval-des-Rapides CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
C-21-keto lupane derivatives preparation and use thereof Grant 8,431,556 - Moinet , et al. April 30, 2	2013-04-30
Lupane derivatives useful for treating HIV Grant 8,269,026 - Moinet , et al. September 18, 2	2012-09-18
Spirotropane compounds Grant 8,124,613 - Moinet , et al. February 28, 2	2012-02-28
Spirotropane compounds and methods for the modulation of chemokine receptor activity Grant 8,076,349 - Chan Chun Kong , et al. December 13, 2	2011-12-13
Spirotropane compounds and methods for the modulation of chemokine receptor activity Grant 7,960,403 - Chan Chun Kong , et al. June 14, 2	2011-06-14
Spirotropane Compounds App 20110105546 - Moinet; Christophe ; et al.	2011-05-05
Novel Lupane Derivatives App 20110077227 - Moinet; Christophe ; et al.	2011-03-31
Novel C-21-keto Lupane Derivatives Preparation And Use Thereof App 20110077228 - Moinet; Christophe ; et al.	2011-03-31
Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity App 20090047238 - Chan Chun Kong; Laval ; et al.	2009-02-19
Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity App 20080267906 - Chan Chun Kong; Laval ; et al.	2008-10-30
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity Grant 7,351,713 - Chan Chun Kong , et al. April 1, 2	2008-04-01
Spiro compounds and methods for the modulation of chemokine receptor activity Grant 7,288,548 - Chan Chun Kong , et al. October 30, 2	2007-10-30
Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer Grant 6,960,594 - Labrecque , et al. November 1, 2	2005-11-01
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity App 20050075360 - Chan Chun Kong, Laval ; et al.	2005-04-07
Spiro compounds and methods for the modulation of chemokine receptor activity App 20050075326 - Chan Chun Kong, Laval ; et al.	2005-04-07
Spiro compounds and methods for the modulation of chemokine receptor activity App 20050070563 - Kong, Laval Chan Chun ; et al.	2005-03-31
Quinolizinones as integrin inhibitors Grant 6,630,488 - Lamothe , et al. October 7, 2	2003-10-07
Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer App 20020137947 - Labrecque, Denis ; et al.	2002-09-26
Antineoplastic heteronapthoquinones Grant 5,736,523 - Attardo , et al. April 7, 1	1998-04-07
Processes antineoplastic heteronaphthoquinones Grant 5,606,037 - Attardo , et al. February 25, 1	1997-02-25
Heterocyclic anthracycline analogs Grant 5,593,970 - Attardo , et al. January 14, 1	1997-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.